Back to Top Skip to main content Skip to sub-navigation

DOD P&T Committee: 2020 Meetings

Nov. 4-5, 2020

Uniform Formulary Request for Quote Information

  • UF BPA & UF ADP RFQ Documents Posted: July 31, 2020
  • Pre-Proposal Teleconference: Aug. 12, 2020 @ 1:00 p.m. Central
  • Clinical/Cost Presentation Meeting Window: (no clinical presentations requested)
  • UF BPA & UF ADP Class Quotes Due: Sept. 18, 2020
Class Review Designated Newly Approved Drugs  Drugs in Previously Reviewed Classes
 
  • ADHD AGENTS - STIMULANTS:

    • Adderall
    • Adderal XR
    • Adhansia XR
    • Azdenys ER
    • Adzenys XR ODT
    • Aptensio XR
    • Concerta
    • Cotempla XR ODT
    • Daytrana
    • Desoxyn
    • Dexedrine
    • Dextrostat
    • Dyanavel XR
    • Evekeo
    • Evekeo ODT
    • Focalin
    • Focalin XR
    • Jornay PM
    • Metadate CD
    • Metadate ER
    • Methylin solution, tab chew
    • Methylin ER
    • Mydayis
    • Procentra
    • Quillichew ER
    • Quillivant XR
    • Ritalin
    • Ritalin LA
    • Ritalin SR
    • Vyyanse Capsule
    • Vyvanse Chewable
    • Zenzedi

  • RESPIRATORY INTERLEUKINS - NA
    • Nucala
    • Dupixent
    • Fasenra

*Please note that all agents in the class, including brands and all generics, may be considered for formulary management  actions.  Additionally, if a drug is approved prior to 27 August 2015, but not currently available the committee may still make a formulary recommendation. 

 
  • AirDuo Digihaler
  • ArmonAir Digihaler
  • Bafiertam 
  • Breztri Aerosphere
  • Conjupri 
  • Cystadrops
  • Dojolvi
  • Dupixent Pen
  • Enspryng 
  • Evrysdi
  • Gavreto
  • Gimoti
  • Hemady
  • Inqovi
  • Kesimpta
  • Lampit 
  • Mycapssa
  • Ongentys
  • Onureg
  • Ortikos
  • Rukobia
  • Semglee
  • Sevenfact
  • Upneeq
  • Xywav
 
  • Glumetza 
  • Lexette
  • Vimovo

Aug. 5-6, 2020

Uniform Formulary Request for Quote Information

  • UF BPA & UF ADP RFQ Documents Posted: May 6, 2020
  • Pre-Proposal Teleconference: May 13, 2020 @ 1:00 p.m. Central
  • Clinical/Cost Presentation Meeting Window: (no clinical presentations requested)
  • UF BPA & UF ADP Class Quotes Due: June 26, 2020*
Class Review  Designated Newly Approved Drugs Drugs in Previously Reviewed Classes 
  • PSORIASIS AGENTS - NA:

    • Calcitriol
    • Calcitrene
    • Calcipotriene Clobetasol
    • Calcipotriene Monohydrate
    • Dovonex
    • Enstilar
    • Oxsoralen-Ultra
    • Soriatane
    • Sorilux
    • Taclonex
    • Tazorac
    • Vectical

  • SLEEP DISORDERS - WAKEFULNESS PROMOTING AGENTS
    • Nuvigil
    • Provigil
    • Sunosi
    • Wakix
    • Xyrem

  • WHITE BLOOD CELL STIMULANTS - FILGRASTIMS
    • Granix
    • Neupogen
    • Nivestym
    • Zarxio

  • WHITE BLOOD CELL STIMULANTS - PEGFILGRASTIMS
    • Fulphila 
    • Neulasta
    • Udenyca
    • Ziextenzo

*Please note that all agents in the class, including brands and all generics, may be considered for formulary management actions.  This reflects the delay of the May 2020 P&T meeting Drug Class reviews to August 2020 as noted in the May meeting website posting.  Updated utilization data reflecting the past 3 months has been posted to betasam. 

  • Arazlo
  • Bynfezia
  • Dayvigo
  • Fensolvi
  • Fintepla
  • Halog
  • Isturisa
  • Koselugo
  • Kynmobi
  • Licart
  • Lyumjev
  • Nexlizet
  • Nymalize
  • Oriahnn
  • Pemazyre
  • Phexxi
  • Qinlock
  • Retevmo
  • Tabrecta
  • Tukysa
  • Twirla
  • Zeposia
  • Zilxi
 

May 6, 2020

Uniform Formulary Request for Quote Information

  • Uniform Formulary Request for Quote Information (UPDATED April 16, 2020)
  • Pre-Proposal Teleconference: Feb. 12, 2020 @ 1:00 p.m.Central
  • Clinical/Cost Presentation Meeting Window: (no clinical presentations requested)
  • UF BPA & UF ADP Class Quotes Due: June 26, 2020*
Class Review  Designated Newly Approved Drugs Drugs in Previously Reviewed Classes 
  • PSORIASIS AGENTS - NA*                  
  • SLEEP DISORDERS - WAKEFULNESS PROMOTING AGENTS*
  • WHITE BLOOD CELL STIMULANTS - FILGRASTIMS*
  • WHITE BLOOD CELL STIMULANTS - PEGFILGRASTIMS*

*All May 2020 P&T Drug Class Reviews have been delayed due to the COVID-19 Pandemic.  We expect to review all classes at the August 2020 P&T Meeting.  Please note the new quote solicitation due date of June 26, 2020.  Please contact the RFQ POC with any questions mailto:dha.san-antonio-tx.healthcare-ops.mbx.pharmacy-opsmbxpod-industr@mail.mil.

 
  • Ayvakit
  • Bonsity
  • Caplyta
  • Esperoct
  • Ibrance Tablets
  • Nexletol
  • Nurtec ODT
  • Palforzia
  • Reyvow
  • Riomet ER
  • Tazverik
  • Trijardy XR
  • Ubrelvy
  • Valtoco
  • Xcopri
  • Zerviate
 

Feb. 5-6, 2020

Uniform Formulary Request for Quote Information

  • UF BPA & UF ADP RFQ Documents Posted: Nov. 1, 2019
  • Pre-Proposal Teleconference: Nov. 13, 2019 @ 12:00 p.m. Central 
  • Clinical/Cost Presentation Meeting Window: (no clinical presentations requested)
  • UF BPA & UF ADP Quotes Due: Dec. 20, 2019  
Class Review  Designated Newly Approved Drugs Drugs in Previously Reviewed Classes 
  • PAIN AGENTS - NSAID:
    • Duexis
    • Qmiiz ODT
    • Sprix
    • Tivorbex
    • Vimovo
    • Vivlodex
    • Zipsor
    • Zorvolex
    • Anaprox DS, generics
    • Ansaid, generics
    • Arthrotec, generics
    • Cambia, generics
    • Cataflam, generics
    • Celebrex, generics
    • Choline magnesium trisalicylate, generics
    • Clinoril, generics
    • Daypro, generics
    • Diflunisal, generics
    • Disalcid, generics
    • Dyloject, generics
    • Feldene, generics
    • Fenortho, generics
    • Ibu, generics
    • Indocin IR, generics
    • Indocin ER, generics
    • Indocin Rectal, generics
    • Indocin Suspension, generics
    • Lodine, generics
    • Lodine XL, generics
    • Meclomen, generics
    • Mobic, generics
    • Nalfon, generics
    • Naprelan CR, generics
    • Naproxen IR, generics
    • Naproxen DR, generics
    • Naproxen Suspension, generics
    • Orudis, generics
    • Oruvail, generics
    • Ponstel, generics
    • Profeno, generics
    • Relafen, generics
    • Tolectin, generics
    • Toradol cartridge, generics
    • Toradol syringe, generics
    • Toradol tablet, generics
    • Toradol vial, generics
    • Voltaren DR, generics
    • Voltaren XR tablet, generics

  • PAIN AGENTS - PAIN TOPICAL:
    • Diclofono
    • Flector, generics
    • Lidoderm, generics
    • Pennsaid drops, generics
    • Pennsaid Pump
    • Voltaren, generics
    • ZTLido
  • Aklief
  • Amzeeq
  • Brukinsa
  • Consensi
  • Enzoclear
  • Fasenra Pen
  • Gloperba
  • Jatenzo
  • Oxbryta
  • Ozobax
  • Pretomanid
  • Proair Digihaler
  • Secuado
  • Talicia
  • Trikafta
  • Vumerity
  • Ziextenzo
 
Last Updated: June 30, 2022

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.